CHEPLAPHARM ARZNEIMITTEL GMBH 5.5 percent 15Jan2028 is a Senior Secured Note issued by the corporate entity on the 8th of October 2020. CHEPLAPHARM is trading at 88.50 as of the 31st of January 2025, a 0.57% up since the beginning of the trading day. The bond's open price was 88.0. CHEPLAPHARM has about a 40 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Ratings for CHEPLAPHARM ARZNEIMITTEL GMBH are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of September 2024 and ending today, the 31st of January 2025. Click here to learn more.
Our tools can tell you how much better you can do entering a position in CHEPLAPHARM without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Equity Valuation Now
Equity Valuation
Check real value of public entities based on technical and fundamental data
Other Information on Investing in CHEPLAPHARM Bond
CHEPLAPHARM financial ratios help investors to determine whether CHEPLAPHARM Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CHEPLAPHARM with respect to the benefits of owning CHEPLAPHARM security.